The School of Public Health champions a commitment to equity and social justice and prioritizes its global approach to health education, scholarship, and community engagement. Many of Rutgers’ public health faculty are engaged in global health, given the myriad connections between the two fields.
Exposure to common cold-causing coronaviruses may contribute to pre-existing immunity to COVID-19, according to a study published in the Journal of Clinical Virology Plus. Rutgers Global Health Institute assistant professor Bobby Brooke Herrera is a lead author.
Botswana-Rutgers Partnership for Health researchers review treatments that could improve outcomes for patients in a region where cancer rates are rising significantly. The study is published in the journal PLOS Global Public Health.
As part of an NIH initiative, Rutgers researchers will provide serologic antibody testing to help determine the incidence and effects of long COVID on children. The testing will be performed in the laboratory of Maria Laura Gennaro, a core faculty member of Rutgers Global Health Institute.
Rutgers Is Awarded $20 Million to Lead Consortium of Seven Universities and Eight Nations to Curb Tuberculosis
New Jersey Medical School will coordinate a worldwide effort to stop one of the deadliest infectious diseases from spreading.
The principal faculty of Rutgers Global Health Institute are innovators. They’re confronting diverse global health challenges – the critical issues that affect everyone, and the complex problems that are especially detrimental to the most vulnerable among us.
Funded by Global Health Seed Grants, five faculty-led efforts will address disparities related to adolescent pregnancy and sexual health information, immigrant health care access, tuberculosis disease prevention, health communication training, and dementia among indigenous older adults.
Ubydul Haque conducts data-based research for predicting locations of infectious disease outbreaks and examining climate-related health hazards. He will be an assistant professor of global health with a joint appointment at Rutgers School of Public Health.
Rutgers Global Health Institute principal faculty member Bobby Brooke Herrera spoke with Verywell Health about the use of rapid antigen tests to detect Omicron variants of the SARS-CoV-2 virus that causes COVID-19.
The program, called Cancer Kitso, is being developed by the Botswana-Rutgers Partnership for Health to educate health care workers about cancer care and prevention. Pharmacists Joyce Kgatlwane and Jiyeon Joy Park discuss their involvement.